89bio, Inc. (ETNB)
USD 5.0
(-9.84%)
USD 5.0
(-9.84%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -289.05 Million USD | -720.94% |
| 2022 | -35.21 Million USD | 73.19% |
| 2021 | -131.34 Million USD | 35.82% |
| 2020 | -204.65 Million USD | -119.21% |
| 2019 | -93.36 Million USD | -791.04% |
| 2018 | 13.51 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -190.27 Million USD | 34.17% |
| 2024 Q2 | -184.87 Million USD | 2.84% |
| 2023 Q2 | -220.68 Million USD | 37.06% |
| 2023 Q4 | -289.05 Million USD | -27.3% |
| 2023 Q1 | -350.61 Million USD | -895.79% |
| 2023 FY | -289.05 Million USD | -720.94% |
| 2023 Q3 | -227.06 Million USD | -2.89% |
| 2022 Q2 | -40.96 Million USD | -15.67% |
| 2022 FY | -35.21 Million USD | 73.19% |
| 2022 Q4 | -35.21 Million USD | 32.78% |
| 2022 Q3 | -52.37 Million USD | -27.87% |
| 2022 Q1 | -35.41 Million USD | 73.04% |
| 2021 Q1 | -189.65 Million USD | 7.33% |
| 2021 FY | -131.34 Million USD | 35.82% |
| 2021 Q4 | -131.34 Million USD | 15.76% |
| 2021 Q3 | -155.91 Million USD | -354.73% |
| 2021 Q2 | -34.28 Million USD | 81.92% |
| 2020 Q1 | -85.53 Million USD | 8.38% |
| 2020 FY | -204.65 Million USD | -119.21% |
| 2020 Q3 | -219.15 Million USD | -221.34% |
| 2020 Q4 | -204.65 Million USD | 6.62% |
| 2020 Q2 | -68.19 Million USD | 20.26% |
| 2019 Q2 | -21.91 Million USD | -295.11% |
| 2019 Q4 | -93.36 Million USD | -476.72% |
| 2019 Q1 | 11.23 Million USD | 200.0% |
| 2019 FY | -93.36 Million USD | -791.04% |
| 2019 Q3 | -16.18 Million USD | 26.15% |
| 2018 Q4 | -11.23 Million USD | 0.0% |
| 2018 FY | 13.51 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Keros Therapeutics, Inc. | -316.7 Million USD | 8.731% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 115.458% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1621.681% |
| AlloVir, Inc. | -62.69 Million USD | -361.068% |
| Precigen, Inc. | -481 Thousand USD | -59994.179% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -64.956% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -12375.168% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1460.773% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4832.645% |
| Acelyrin, Inc. | -216.9 Million USD | -33.264% |
| AbCellera Biologics Inc. | -55.94 Million USD | -416.72% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 360.713% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2283.345% |
| Agenus Inc. | 274.13 Million USD | 205.441% |
| Dyadic International, Inc. | -6.37 Million USD | -4431.962% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1714.178% |
| Lantern Pharma Inc. | -21.7 Million USD | -1231.84% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1550.808% |
| IO Biotech, Inc. | -140.69 Million USD | -105.441% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2476.442% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -273.208% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -123.874% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -417.423% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 571.869% |
| Alkermes plc | -166.73 Million USD | -73.357% |
| Aptorum Group Limited | 1.35 Million USD | 21400.162% |
| Ardelyx, Inc. | 34.51 Million USD | 937.543% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 6853.575% |
| Bicycle Therapeutics plc | -481.46 Million USD | 39.964% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 899.306% |
| Chimerix, Inc. | -25.51 Million USD | -1032.786% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 4248.247% |
| CRISPR Therapeutics AG | -150.84 Million USD | -91.623% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1411.942% |
| ESSA Pharma Inc. | -33.62 Million USD | -759.725% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3871.076% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3871.076% |
| NextCure, Inc. | -6.47 Million USD | -4362.761% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -472.371% |
| Onconetix, Inc. | 5.33 Million USD | 5521.671% |
| Opthea Limited | 28.15 Million USD | 1126.56% |
| PDS Biotechnology Corporation | -32.7 Million USD | -783.714% |
| GT Biopharma, Inc. | -1.02 Million USD | -28210.774% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -161.499% |
| ImmuCell Corporation | 10.99 Million USD | 2730.011% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -87.519% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3283.437% |
| Incyte Corporation | -3.17 Billion USD | 90.896% |
| Jaguar Health, Inc. | 29.39 Million USD | 1083.475% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 5516.02% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -5788.226% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1986.122% |
| ContextLogic Inc. | -232 Million USD | -24.592% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1772.954% |
| MiMedx Group, Inc. | -33.9 Million USD | -752.639% |
| MEI Pharma, Inc. | -3.7 Million USD | -7701.7% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2935.243% |
| Seer, Inc. | -4.24 Million USD | -6717.288% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -5052.215% |
| Novavax, Inc. | -298.29 Million USD | 3.098% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2152.787% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4431.322% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -848.959% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -71.817% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 278.712% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 4292.456% |
| Vaxcyte, Inc. | -368.22 Million USD | 21.501% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -419.749% |
| Pharming Group N.V. | 109.8 Million USD | 363.245% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -19.264% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1561.606% |
| PureTech Health plc | -167.19 Million USD | -72.882% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1140.021% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1460.773% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3971.169% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -16666.415% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -4148.905% |
| Senti Biosciences, Inc. | 1.74 Million USD | 16712.241% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -56.577% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -4668.278% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 289822.258% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 46127.548% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1102.534% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -146.957% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2410.391% |
| ChromaDex Corporation | -24.04 Million USD | -1101.984% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -3705.332% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1120.818% |
| Precision BioSciences, Inc. | -85.41 Million USD | -238.43% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 568.74% |
| Innoviva, Inc. | 255.56 Million USD | 213.104% |
| Summit Therapeutics Inc. | 34.67 Million USD | 933.63% |
| GlycoMimetics, Inc. | -40.98 Million USD | -605.275% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -326.439% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -115.584% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -901.153% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -383595.277% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -836.598% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3427.249% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -9137.818% |
| Soligenix, Inc. | -4.95 Million USD | -5737.571% |
| Century Therapeutics, Inc. | 847 Thousand USD | 34226.682% |
| Kura Oncology, Inc. | -20.11 Million USD | -1336.788% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -606.282% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3341.927% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 15967.255% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -8941.383% |
| Autolus Therapeutics plc | -186.59 Million USD | -54.906% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -486.267% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -4.808% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 943.507% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 275.857% |
| GRI Bio, Inc. | -1.79 Million USD | -16012.207% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3117.762% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -769.149% |
| IGM Biosciences, Inc. | -72.6 Million USD | -298.112% |
| INmune Bio, Inc. | -25.41 Million USD | -1037.511% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 291.488% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -470.586% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1678.856% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -9919.425% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 860.366% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -601.84% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1006.549% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 176.479% |
| Verastem, Inc. | -37.27 Million USD | -675.398% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3085.859% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -457.35% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1809.832% |
| Histogen Inc. | -7.48 Million USD | -3760.732% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1237.786% |
| Surrozen, Inc. | -32.66 Million USD | -784.928% |
| Organovo Holdings, Inc. | -1.5 Million USD | -19080.69% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6776.504% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1624.524% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 11149.427% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 7055.077% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3348.847% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -565.377% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1882.958% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 8.755% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -39931.715% |
| Apollomics, Inc. | -27.39 Million USD | -955.13% |
| Amarin Corporation plc | -191.04 Million USD | -51.305% |
| Mesoblast Limited | 55.96 Million USD | 616.507% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1881.987% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1042.863% |
| Synaptogenix, Inc. | -28.66 Million USD | -908.506% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -30781.731% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 693.148% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -33429.369% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3878.115% |
| Exelixis, Inc. | -73.05 Million USD | -295.692% |
| Better Therapeutics, Inc. | -860 Thousand USD | -33510.814% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1103.735% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -19.755% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 39369.984% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3786.095% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 23150.478% |
| Gritstone bio, Inc. | 39.49 Million USD | 831.965% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -243.697% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -10881.673% |
| Avid Bioservices, Inc. | 169.72 Million USD | 270.304% |
| Insmed Incorporated | 721.62 Million USD | 140.056% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3061.982% |
| MediWound Ltd. | -5.32 Million USD | -5331.285% |
| OmniAb, Inc. | 9.2 Million USD | 3240.856% |
| Alector, Inc. | -35.63 Million USD | -711.104% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 436.222% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -5765.524% |
| Zai Lab Limited | -775 Million USD | 62.703% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 184.877% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1242.871% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -250.452% |
| Immunic, Inc. | -45.34 Million USD | -537.523% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -49.602% |
| Veracyte, Inc. | -203.82 Million USD | -41.815% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 145.285% |
| FibroGen, Inc. | 56.76 Million USD | 609.192% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3345.963% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -10124.429% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -13861.566% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 106.297% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -8551.691% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -74.166% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1718.257% |
| Galecto, Inc. | -21.21 Million USD | -1262.429% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1115.274% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 118.418% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1081.158% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2411.975% |
| XBiotech Inc. | -200.02 Million USD | -44.51% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -243.697% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 6483.679% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -719.706% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -274.334% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 5179.125% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -69.617% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -212.916% |
| Vaxxinity, Inc. | 10.13 Million USD | 2952.872% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 139.259% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2584.482% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -338.251% |
| NexImmune, Inc. | -3.13 Million USD | -9124.184% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -8271.861% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1812.808% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -966.616% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3120.268% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -231931.306% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -612.445% |
| Ainos, Inc. | 4.07 Million USD | 7188.232% |
| Pluri Inc. | 22.82 Million USD | 1366.166% |
| Prothena Corporation plc | -608.34 Million USD | 52.486% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -143.401% |
| Celularity Inc. | 65.19 Million USD | 543.401% |
| Rallybio Corporation | -24.1 Million USD | -1099.291% |
| Cue Biopharma, Inc. | -33.81 Million USD | -754.706% |
| MeiraGTx Holdings plc | -40.3 Million USD | -617.218% |
| Omeros Corporation | 331.17 Million USD | 187.281% |
| Humacyte, Inc. | -22.48 Million USD | -1185.48% |
| Immunocore Holdings plc | -358.59 Million USD | 19.393% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1076.208% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -835.416% |
| Blueprint Medicines Corporation | 702.83 Million USD | 141.127% |
| CalciMedica, Inc. | -5.53 Million USD | -5126.998% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -53.572% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2729.969% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -621.965% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -769.254% |
| Pulmatrix, Inc. | -10.41 Million USD | -2674.82% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -4736.088% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -657.834% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -159.468% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -382.205% |
| Cytokinetics, Incorporated | 642.37 Million USD | 144.998% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -4863.988% |
| Nutriband Inc. | -251.65 Thousand USD | -114759.909% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -747.191% |
| Vor Biopharma Inc. | 4.3 Million USD | 6822.163% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 95.211% |
| Evogene Ltd. | -19.63 Million USD | -1372.206% |
| ProKidney Corp. | -56.23 Million USD | -414.0% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -493.879% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3029.232% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 121.193% |
| CorMedix Inc. | -43.05 Million USD | -571.396% |
| BioLineRx Ltd. | 7.33 Million USD | 4040.199% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -952.441% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 726.374% |
| Atai Life Sciences N.V. | -28.55 Million USD | -912.161% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 13058.944% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1166.887% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1729.845% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -285.024% |
| MediciNova, Inc. | -50.78 Million USD | -469.187% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -266.795% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1284865.548% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4379.644% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -44.656% |
| Biomea Fusion, Inc. | -166.57 Million USD | -73.532% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -61.505% |
| Mereo BioPharma Group plc | -51.46 Million USD | -461.606% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -204.767% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 1.602% |
| Absci Corporation | -72.59 Million USD | -298.156% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6430.552% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -23.297% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -206.814% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -202.053% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -639.777% |
| Allakos Inc. | -24.97 Million USD | -1057.369% |
| Imunon, Inc. | -4.21 Million USD | -6759.591% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1860.745% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -113.481% |
| BioAtla, Inc. | -109.01 Million USD | -165.159% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 39369.984% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -30683.067% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2515.619% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1263.265% |
| XOMA Corporation | -29 Million USD | -896.734% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1645.489% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3106.0% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3780.427% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -131.918% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -38.858% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -253.456% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -211.604% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -33542.735% |
| Akari Therapeutics, Plc | -3.84 Million USD | -7417.633% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 17911.004% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 120.933% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -24228.296% |
| UroGen Pharma Ltd. | 4.39 Million USD | 6682.851% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 354.715% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 401774.495% |
| Orgenesis Inc. | 21.78 Million USD | 1426.905% |
| Entera Bio Ltd. | -10.62 Million USD | -2619.475% |
| GH Research PLC | -78.07 Million USD | -270.215% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1196.9% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -984.26% |
| Xencor, Inc. | 29.64 Million USD | 1075.081% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -14574.141% |
| Replimune Group, Inc. | 1.41 Million USD | 20571.176% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -117925.136% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -128.65% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -24228.296% |
| Portage Biotech Inc. | -4.98 Million USD | -5703.112% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1284865.548% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -337.151% |
| OncoCyte Corporation | -6.56 Million USD | -4304.282% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 32309.585% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -6244.944% |
| Purple Biotech Ltd. | -14.13 Million USD | -1944.511% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1116.758% |
| scPharmaceuticals Inc. | -6.54 Million USD | -4316.394% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1631.669% |
| HilleVax, Inc. | -165.48 Million USD | -74.67% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -11289.007% |
| Tharimmune, Inc. | -10.93 Million USD | -2543.289% |
| Genprex, Inc. | -6.73 Million USD | -4190.129% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 21.625% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -226.761% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -20531.906% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -8614.432% |
| OKYO Pharma Limited | -826.84 Thousand USD | -34858.42% |
| Savara Inc. | 153 Thousand USD | 189023.529% |
| Curis, Inc. | -23.88 Million USD | -1110.085% |
| Daré Bioscience, Inc. | -5.15 Million USD | -5504.071% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -37148.522% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -4556.137% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 24492.658% |
| BeiGene, Ltd. | -2.25 Billion USD | 87.171% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2442.692% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 52.474% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -55.752% |
| Erasca, Inc. | -37.21 Million USD | -676.69% |
| bluebird bio, Inc. | 108.57 Million USD | 366.234% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -22343.868% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 176.318% |
| DBV Technologies S.A. | -126.98 Million USD | -127.626% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -22343.868% |
| Moderna, Inc. | -2.9 Billion USD | 90.057% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2692.243% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2559.671% |
| Molecular Templates, Inc. | 707 Thousand USD | 40984.441% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -821.402% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 183.395% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -252.237% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -215.113% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -795.677% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -740.857% |
| MacroGenics, Inc. | -66.98 Million USD | -331.519% |
| RenovoRx, Inc. | -1.17 Million USD | -24542.199% |
| Adicet Bio, Inc. | -138.78 Million USD | -108.271% |
| Prime Medicine, Inc. | -27.94 Million USD | -934.512% |
| Aditxt, Inc. | 18.12 Million USD | 1695.137% |
| Adagene Inc. | -87.62 Million USD | -229.866% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6839.335% |
| Quantum-Si incorporated | -118.55 Million USD | -143.809% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 902.813% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3767.35% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -495.875% |
| SciSparc Ltd. | -2.06 Million USD | -13897.724% |
| Vericel Corporation | 1.27 Million USD | 22735.317% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2310.442% |
| Minerva Neurosciences, Inc. | 41 Million USD | 804.934% |
| Generation Bio Co. | 31.44 Million USD | 1019.146% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -64.83% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -834.751% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 347.916% |
| Invivyd, Inc. | -198.47 Million USD | -45.636% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -220.209% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -11955.487% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -308.325% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -4135.209% |
| 2seventy bio, Inc. | 181.71 Million USD | 259.069% |
| ADMA Biologics, Inc. | 90.06 Million USD | 420.935% |
| Clene Inc. | 3.34 Million USD | 8754.281% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3082.456% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1243.745% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4379.644% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 16.003% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1011.756% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 262.695% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -6964.604% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 5878.749% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -5449.107% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -121.83% |
| Evaxion Biotech A/S | 5.28 Million USD | 5567.402% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -156.781% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -120.192% |
| Trevena, Inc. | 2.25 Million USD | 12901.284% |
| Surrozen, Inc. | -32.66 Million USD | -784.928% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -461.159% |
| Cingulate Inc. | 3.08 Million USD | 9476.67% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -9741.777% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 4121.887% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3011.032% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -264.4% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -119.892% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -173.875% |
| Clearmind Medicine Inc. | -3.94 Million USD | -7231.464% |
| Kronos Bio, Inc. | -36.05 Million USD | -701.722% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3172.091% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 19923.582% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -432.758% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2105.028% |
| ImmunityBio, Inc. | 618.22 Million USD | 146.755% |
| Korro Bio, Inc. | -132.94 Million USD | -117.426% |
| Kineta, Inc. | -4.54 Million USD | -6265.404% |
| BioVie Inc. | -17.73 Million USD | -1530.088% |
| Codexis, Inc. | -43.27 Million USD | -568.006% |
| Celularity Inc. | 65.19 Million USD | 543.401% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -9021.269% |
| Celcuity Inc. | 6.78 Million USD | 4361.113% |
| Virax Biolabs Group Limited | -3.36 Million USD | -8490.128% |
| Cibus, Inc. | -8.07 Million USD | -3478.274% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -6735.02% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 6425.011% |
| IN8bio, Inc. | -16.38 Million USD | -1663.701% |
| Kodiak Sciences Inc. | -103.87 Million USD | -178.27% |
| Annexon, Inc. | -193.75 Million USD | -49.185% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 803025.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1551.826% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -8128.096% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 127.417% |
| Eyenovia, Inc. | 1.25 Million USD | 23064.371% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1174.347% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8813.136% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -769.411% |
| Arcellx, Inc. | -296.95 Million USD | 2.662% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1381.867% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -390.961% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1294.572% |
| Moolec Science SA | 117.61 Thousand USD | 245859.931% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -652.762% |
| Geron Corporation | 14.76 Million USD | 2058.221% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -662.311% |
| Royalty Pharma plc | 5.65 Billion USD | 105.109% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -104.392% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -4035.577% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -5289.905% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -105.394% |
| Humacyte, Inc. | -22.48 Million USD | -1185.48% |
| Structure Therapeutics Inc. | -124.33 Million USD | -132.472% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1045.127% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -16111.61% |
| Genelux Corporation | -6.89 Million USD | -4089.781% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -830.658% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 445.761% |
| Notable Labs, Ltd. | -9.77 Million USD | -2856.761% |
| Liquidia Corporation | -80.17 Million USD | -260.523% |
| Mustang Bio, Inc. | -3.73 Million USD | -7636.965% |
| Immunovant, Inc. | -635.22 Million USD | 54.496% |
| Quantum-Si incorporated | -118.55 Million USD | -143.809% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1545.713% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -6876.901% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3701.009% |
| Acasti Pharma Inc. | -23 Million USD | -1156.479% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -8484.299% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1678.856% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -109.854% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -9175.335% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1200.166% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1456.643% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -70.756% |
| PepGen Inc. | -60.67 Million USD | -376.435% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1158.065% |
| United Therapeutics Corporation | -507.7 Million USD | 43.066% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1411.309% |
| Solid Biosciences Inc. | -47.75 Million USD | -505.347% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -33429.369% |
| Immuneering Corporation | -54.94 Million USD | -426.097% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6776.504% |
| Silo Pharma, Inc. | -3.52 Million USD | -8101.695% |
| Belite Bio, Inc | -87.27 Million USD | -231.213% |
| XOMA Corporation | -29 Million USD | -896.734% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -308.862% |
| Bionomics Limited | 227 Million USD | 227.331% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -148.579% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -11311.488% |
| uniQure N.V. | -102.95 Million USD | -180.768% |
| Cassava Sciences, Inc. | -121.13 Million USD | -138.619% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6839.335% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 805.851% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2316.629% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -9241.768% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 272791.509% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8813.136% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3345.963% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3797.694% |
| Altimmune, Inc. | -134.48 Million USD | -114.93% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 245.938% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -11311.488% |
| Compugen Ltd. | -12.9 Million USD | -2140.026% |
| Peak Bio, Inc. | 10.34 Million USD | 2895.441% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -102038.869% |
| Benitec Biopharma Inc. | -50.58 Million USD | -471.454% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -177.035% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1571.382% |
| Zura Bio Limited | -99.8 Million USD | -189.615% |
| PolyPid Ltd. | 6.17 Million USD | 4784.814% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 489.98% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1571.382% |
| Instil Bio, Inc. | 75.35 Million USD | 483.573% |
| argenx SE | -2.02 Billion USD | 85.753% |
| Immunome, Inc. | -97.02 Million USD | -197.904% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1184.966% |
| Verona Pharma plc | -220.44 Million USD | -31.124% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -302.901% |
| Shattuck Labs, Inc. | -121.42 Million USD | -138.053% |
| CervoMed Inc. | -7.79 Million USD | -3609.21% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -55.825% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -6509.947% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -119.412% |
| Moolec Science SA | 117.61 Thousand USD | 245859.931% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -12533.562% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1918.129% |
| AnaptysBio, Inc. | -18.15 Million USD | -1492.491% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1492.579% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -310.697% |
| NeurAxis, Inc. | 145.7 Thousand USD | 198489.156% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2673.478% |
| Lumos Pharma, Inc. | -28.49 Million USD | -914.47% |
| Achilles Therapeutics plc | -126.92 Million USD | -127.737% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -302.901% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -43981.1% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1291.429% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 19923.582% |
| Nutriband Inc. | -251.65 Thousand USD | -114759.909% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2094.617% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3785.121% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 184.966% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1317.834% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 35.403% |
| Palisade Bio, Inc. | -12.06 Million USD | -2296.195% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -106.009% |
| Beam Therapeutics Inc. | -262.72 Million USD | -10.022% |
| Neurogene Inc. | -131.95 Million USD | -119.054% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1424.959% |
| AEON Biopharma, Inc. | -4.88 Million USD | -5823.217% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 23.367% |
| Sesen Bio, Inc. | -112.55 Million USD | -156.815% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -189.458% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -12211.69% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -640.668% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -247.077% |
| Athira Pharma, Inc. | -88.99 Million USD | -224.782% |
| Vaccinex, Inc. | -1.28 Million USD | -22342.003% |
| HCW Biologics Inc. | 2.85 Million USD | 10218.508% |
| XOMA Corporation | -29 Million USD | -896.734% |
| Nektar Therapeutics | 210.24 Million USD | 237.487% |
| Arvinas, Inc. | -313.8 Million USD | 7.886% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 17911.004% |
| Merus N.V. | -192.88 Million USD | -49.858% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 581.875% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -4066.229% |
| Rezolute, Inc. | -68.16 Million USD | -324.03% |
| Clene Inc. | 3.34 Million USD | 8754.281% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2091.954% |
| BeyondSpring Inc. | -13.75 Million USD | -2001.439% |
| Synlogic, Inc. | -6.68 Million USD | -4223.904% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 25589.683% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3318.723% |
| Peak Bio, Inc. | 10.34 Million USD | 2895.441% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -250.707% |
| Krystal Biotech, Inc. | -350.23 Million USD | 17.469% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 332.873% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -71.041% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -9055.522% |
| MannKind Corporation | 143.89 Million USD | 300.872% |
| Ikena Oncology, Inc. | -109.15 Million USD | -164.807% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3717.897% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -773.272% |
| Gossamer Bio, Inc. | 180.35 Million USD | 260.269% |
| CohBar, Inc. | -5.93 Million USD | -4773.817% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -871.672% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6430.552% |
| Legend Biotech Corporation | -949.39 Million USD | 69.554% |
| Mural Oncology plc | -255.84 Million USD | -12.981% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 997.262% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -6036.17% |
| Disc Medicine, Inc. | -358.28 Million USD | 19.322% |
| Champions Oncology, Inc. | 4.81 Million USD | 6106.92% |
| REGENXBIO Inc. | 54.76 Million USD | 627.777% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -107391.809% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -91.395% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3107.421% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -258.258% |
| Vaxart, Inc. | -8.24 Million USD | -3407.499% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -476.033% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -127.304% |
| Cellectis S.A. | -43.85 Million USD | -559.111% |
| Longeveron Inc. | -2.9 Million USD | -9839.924% |
| Repare Therapeutics Inc. | -107.85 Million USD | -167.994% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 129.849% |
| Inozyme Pharma, Inc. | 12 Million USD | 2507.972% |
| Revolution Medicines, Inc. | -608.2 Million USD | 52.474% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -23400.244% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -9.028% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -92.61% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1747.338% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -38961.216% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.978% |
| Denali Therapeutics Inc. | -74.86 Million USD | -286.099% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2310.442% |
| Veru Inc. | 4.77 Million USD | 6147.173% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2470.274% |
| Cingulate Inc. | 3.08 Million USD | 9476.67% |
| Passage Bio, Inc. | 4.58 Million USD | 6404.318% |
| Context Therapeutics Inc. | -14.44 Million USD | -1900.391% |
| Exicure, Inc. | 5.84 Million USD | 5041.922% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -25.47% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -630.485% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1942.158% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -391.411% |
| Nuvalent, Inc. | -335.38 Million USD | 13.815% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 16766.446% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -288.084% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3151.44% |
| OmniAb, Inc. | 9.2 Million USD | 3240.856% |
| Anew Medical, Inc. | 1.43 Million USD | 20278.713% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1864.481% |
| Lipocine Inc. | -4.75 Million USD | -5979.449% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -163.187% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1997.794% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -470.586% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1261.229% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -4200.744% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -339.11% |
| Ocugen, Inc. | -32.52 Million USD | -788.82% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -237.777% |
| Q32 Bio Inc. | -37.94 Million USD | -661.708% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -45927.548% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2036.544% |
| Equillium, Inc. | -22.39 Million USD | -1190.876% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1030.526% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -785.938% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -116493.591% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 315.644% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 9138.555% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 88107.587% |
| Dominari Holdings Inc. | 195 Thousand USD | 148332.308% |
| Edesa Biotech, Inc. | -5.26 Million USD | -5388.095% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3141.595% |
| Bio-Techne Corporation | 267.74 Million USD | 207.958% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1683.287% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -144.765% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3339.879% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2184.823% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -17.924% |
| Nkarta, Inc. | 57.29 Million USD | 604.464% |
| BioCardia, Inc. | 212 Thousand USD | 136445.755% |
| Iterum Therapeutics plc | 13.43 Million USD | 2251.012% |